These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37698523)

  • 1. Effect of Neurotoxin Exposure on Blood Biomarkers of Neurodegeneration and Alzheimer Disease.
    Schubert CR; Paulsen AJ; Pinto AA; Chappell RJ; Chen Y; Ferrucci L; Hancock LM; Cruickshanks KJ; Merten N
    Alzheimer Dis Assoc Disord; 2023 Oct-Dec 01; 37(4):310-314. PubMed ID: 37698523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Midlife Lifestyle and Health Factors with Long-Term Changes in Blood-Based Biomarkers of Alzheimer's Disease and Neurodegeneration.
    Merten N; Pinto AA; Paulsen AJ; Chen Y; Engelman CD; Hancock LM; Johnson SC; Schubert CR
    J Alzheimers Dis; 2023; 94(4):1381-1395. PubMed ID: 37393497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of sensory and motor function with blood-based biomarkers of neurodegeneration and Alzheimer's disease in midlife.
    Paulsen AJ; Schubert CR; Pinto AA; Chappell RJ; Chen Y; Cruickshanks KJ; Engelman CD; Ferrucci L; Hancock LM; Johnson SC; Merten N
    Neurobiol Aging; 2022 Dec; 120():177-188. PubMed ID: 36209638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Long-Term Storage on the Reliability of Blood Biomarkers for Alzheimer's Disease and Neurodegeneration.
    Schubert CR; Paulsen AJ; Pinto AA; Merten N; Cruickshanks KJ
    J Alzheimers Dis; 2022; 85(3):1021-1029. PubMed ID: 34924380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.
    Li X; Yucel R; Clervius H; Kamalakar K; Zetterberg H; Blennow K; Zhang J; Adimora A; Collins LF; Fischl M; Kassaye S; Maki P; Seaberg E; Sharma A; Vance D; Gustafson DR
    JAMA Netw Open; 2023 Nov; 6(11):e2344194. PubMed ID: 38019518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest.
    Ashton NJ; Moseby-Knappe M; Benedet AL; Grötschel L; Lantero-Rodriguez J; Karikari TK; Hassager C; Wise MP; Stammet P; Kjaergaard J; Friberg H; Nielsen N; Cronberg T; Zetterberg H; Blennow K
    JAMA Neurol; 2023 Apr; 80(4):388-396. PubMed ID: 36877496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.
    Shir D; Mielke MM; Hofrenning EI; Lesnick TG; Knopman DS; Petersen RC; Jack CR; Algeciras-Schimnich A; Vemuri P; Graff-Radford J
    J Alzheimers Dis; 2023; 92(3):887-898. PubMed ID: 36806507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Mattsson-Carlgren N; Grinberg LT; Boxer A; Ossenkoppele R; Jonsson M; Seeley W; Ehrenberg A; Spina S; Janelidze S; Rojas-Martinex J; Rosen H; La Joie R; Lesman-Segev O; Iaccarino L; Kollmorgen G; Ljubenkov P; Eichenlaub U; Gorno-Tempini ML; Miller B; Hansson O; Rabinovici GD
    Neurology; 2022 Mar; 98(11):e1137-e1150. PubMed ID: 35173015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease.
    Llibre-Guerra JJ; Li Y; Schindler SE; Gordon BA; Fagan AM; Morris JC; Benzinger TLS; Hassenstab J; Wang G; Allegri R; Berman SB; Chhatwal J; Farlow MR; Holtzman DM; Jucker M; Levin J; Noble JM; Salloway S; Schofield P; Karch C; Fox NC; Xiong C; Bateman RJ; McDade E
    JAMA Netw Open; 2019 Dec; 2(12):e1917126. PubMed ID: 31825500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
    Startin CM; Ashton NJ; Hamburg S; Hithersay R; Wiseman FK; Mok KY; Hardy J; Lleó A; Lovestone S; Parnetti L; Zetterberg H; Hye A; ; Strydom A
    Alzheimers Res Ther; 2019 Mar; 11(1):26. PubMed ID: 30902060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma β-Amyloid, Total-Tau, and Neurofilament Light Chain Levels and the Risk of Stroke: A Prospective Population-Based Study.
    Heshmatollah A; Fani L; Koudstaal PJ; Ghanbari M; Ikram MA; Ikram MK
    Neurology; 2022 Apr; 98(17):e1729-e1737. PubMed ID: 35232820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.
    McCarter SJ; Lesnick TG; Lowe VJ; Rabinstein AA; Przybelski SA; Algeciras-Schimnich A; Ramanan VK; Jack CR; Petersen RC; Knopman DS; Boeve BF; Kantarci K; Vemuri P; Mielke MM; Graff-Radford J
    J Alzheimers Dis; 2022; 87(4):1537-1547. PubMed ID: 35527558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg.
    Dittrich A; Ashton NJ; Zetterberg H; Blennow K; Zettergren A; Simrén J; Skillbäck T; Shams S; Machado A; Westman E; Schöll M; Skoog I; Kern S
    Neurology; 2023 Jul; 101(3):e277-e288. PubMed ID: 37225431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament light chain in the vitreous humor of the eye.
    Subramanian ML; Vig V; Chung J; Fiorello MG; Xia W; Zetterberg H; Blennow K; Zetterberg M; Shareef F; Siegel NH; Ness S; Jun GR; Stein TD
    Alzheimers Res Ther; 2020 Sep; 12(1):111. PubMed ID: 32943089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
    Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
    J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light.
    Schindler SE; Karikari TK; Ashton NJ; Henson RL; Yarasheski KE; West T; Meyer MR; Kirmess KM; Li Y; Saef B; Moulder KL; Bradford D; Fagan AM; Gordon BA; Benzinger TLS; Balls-Berry J; Bateman RJ; Xiong C; Zetterberg H; Blennow K; Morris JC
    Neurology; 2022 Jul; 99(3):e245-e257. PubMed ID: 35450967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.